We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Asthma Treatments on Daily Activities

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2006 by Ovation Research Group.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00350376
First Posted: July 10, 2006
Last Update Posted: July 10, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Genentech, Inc.
Information provided by:
Ovation Research Group
July 5, 2006
July 10, 2006
July 10, 2006
June 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Impact of Asthma Treatments on Daily Activities
Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.
Not Provided
Observational
Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Asthma
  • Allergies
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
1500
Not Provided
Not Provided

Inclusion Criteria:

  • Have asthma and allergies
  • Currently taking Xolair® or Advair®
  • Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
  • Between 18 and 55 years of age
  • A non-smoker for at least 6 months
  • Have internet access
Sexes Eligible for Study: All
18 Years to 55 Years   (Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00350376
1467
Not Provided
Not Provided
Not Provided
Not Provided
Ovation Research Group
Genentech, Inc.
Principal Investigator: Susan D Mathias, MPH Ovation Research Group
Ovation Research Group
July 2006